The coverage of treatment interventions for substance use disorders is defined as the number of people who received treatment in a year divided by the total number of people with substance use disorders in the same year. This indicator is disaggregated by two broad groups of psychoactive substances: (1) drugs, (2) alcohol and other psychoactive substances.
Tags: SDGs; Survey data; Annual Report Questionnaire (ARQ)
Country report description ...
Tags: Access & Functioning of Justice, Corruption & Economic Crime, Drug Trafficking & Cultivation, Drug Use & Treatment, Firearms Trafficking, Intentional Homicide, Prisons & Prisoners, SDGs; Administrative data, Survey data; Annual Report Questionnaire (ARQ), Global Report on Trafficking in Persons (GLOTIP), United Nations Survey of Crime Trends and Operations of Criminal Justice Systems (UN-CTS), Illicit Arms Flows Questionnaire (UN-IAFQ), Individual Drug Seizure Cases (IDS)
Dataset on people who inject drug, and the prevalence rates of infectious diseases (HIV, HCV and HBV) among those people. Data are disaggregated by sex (female, male).
Tags: Drug Use & Treatment; Administrative data; Annual Report Questionnaire (ARQ)
Dataset on regional estimates on people who inject drug, and the prevalence rates of infectious diseases (HIV, HCV and HBV) among those people. Data are disaggregated by sex (female, male).
Tags: Drug Use & Treatment; Administrative data; Annual Report Questionnaire (ARQ)
Dataset on the prevalence of drug use defined as the annual prevalence of use as a percentage of the population aged 15-64. Data are disaggregated by drug (cannabis, cocaine, amphetamines, ‘ecstasy’-type substance, prescription stimulants, opioids) and sex (female, male).
Tags: Drug Use & Treatment; Administrative data; Annual Report Questionnaire (ARQ)
Dataset on the annual prevalence of drug use among the youth population, expressed as a percentage. Data are disaggregated by drug type (cannabis, cocaine, amphetamines, ecstasy-type substances, prescription stimulants, opioids) and by sex (female, male).
Tags: Drug Use & Treatment; Administrative data; Annual Report Questionnaire (ARQ)
Dataset on regional estimates on the prevalence of drug use defined as the annual prevalence of use as a percentage of the population aged 15-64. Data are disaggregated by drug (Amphetamines and prescription stimulants, cannabis, cocaine, ecstasy, opiates and opioids (opiates and prescription opioids) and sex (female, male).
Tags: Drug Use & Treatment; Administrative data; Annual Report Questionnaire (ARQ)
Dataset on the prevalence of drug use of new psychoactive substances (NPS) in the youth population defined as the annual prevalence of use as a percentage of the population. Data are disaggregated by NPS type and substance (Synthetic cannabinoids, Ketamine, Miscellaneous NPS: Pregabalin, Kratom, Synthetic cathinones, Mephedrone, NPS, Other NPS (except ketamine and SCRA), Galaxy, Other NPS, Other NPS (except ketamine and "magic mushrooms"), MDPV, Synthetic cathinones and other stimulant NPS, 3-MMC, 4-FA, Mephedrone (4-methylmethcathinone, 4-MMC), Piperazines, BZP. Plant-based substances: Khat, Salvia Divinorum, Mitragyna speciosa (kratom)-leaves, Mitragyna speciosa (kratom)-liquid, magic mushrooms) and sex (female, male).
Tags: Drug Use & Treatment; Administrative data; Annual Report Questionnaire (ARQ)
Dataset on the prevalence of drug use of new psychoactive substances (NPS) defined as the annual prevalence of use as a percentage of the population aged 15-64. Data are disaggregated by NPS type and substance (Synthetic cannabinoids, Ketamine, Miscellaneous NPS: Pregabalin, Kratom, Synthetic cathinones, Mephedrone, NPS, Other NPS (except ketamine and SCRA), Galaxy, Other NPS, Other NPS (except ketamine and "magic mushrooms"), MDPV, Synthetic cathinones and other stimulant NPS, 3-MMC, 4-FA, Mephedrone (4-methylmethcathinone, 4-MMC), Piperazines, BZP. Plant-based substances: Khat, Salvia Divinorum, Mitragyna speciosa (kratom)-leaves, Mitragyna speciosa (kratom)-liquid, magic mushrooms) and sex (female, male).
Tags: Drug Use & Treatment; Administrative data; Annual Report Questionnaire (ARQ)
Dataset the number of treatments by primary drug use. Data are disaggregated by drug group (cannabis-type drugs, opioids, including opiates and synthetic opioids, cocaine-type drugs, amphetamine-type stimulants, “ecstasy”-type substances, non-medical use of pharmaceutical sedatives and tranquillizers, hallucinogens, solvents and inhalants, new psychoactive substances (NPS), other drugs / psychoactive substances / pharmaceutical products not listed above) and sex (female, male).
Tags: Drug Use & Treatment; Administrative data; Annual Report Questionnaire (ARQ)